prevent full NS and potentially effect recovery. Neither patient nor the surgeon should go into the operation assuming that low risk patients will have a full NS. It is important to counsel the patient on the possible adverse effects of surgery in this situation and weigh the risks and benefits of active surveillance in these patients.
INTRODUCTION AND OBJECTIVES: Surgical management of high-risk and non-metastatic prostate cancer has received renewed attention since the publication of the Protect study which suggests at best marginal benefits for low and intermediate risk categories. Tailormade wide excision surgery is generally offered as part of combined modality treatment with adjuvant radiotherapy. Functional outcome in this group of patients is rarely publicised and is expected to reflect the extensive nature of the disease. We prospectively assess the rate of incontinence at follow up of at least one year and compute independent pre-and perioperative predictive parameters of adverse outcome.
METHODS: A total of 178 patients with high risk CaP (44.6% were cT3a/b) underwent laparoscopic radical prostatectomy with pelvic lymphadenectomy from July 2007 to 2016 at Imperial College NHS Trust, London. Pad-use was assessed independently by a specialist nurse from the surgical team at a minimum follow up of 1 year via a telephone clinic and questionnaires. Pre-op factors assessed were: age, psa, Gleason grade, previous TURP, clinical stage, radiological stage, prostate size, family history of prostate cancer, BMI. Peri-op factors assessed were: operating time, blood loss, any nerve sparing, bladder neck sparing, presence of middle lobe, hospital stay, early complication, late complication, Clavien scale complication. Complications were prospectively assessed and graded meticulously with Clavien classification. Univariate and multivariate analysis utilising logistic regression was computed to predict a binary outcome of no versus any pad use.
RESULTS: Pad use at one year after surgery for high risk prostate cancer was 17% and artificial urethral sphincter or advance tape was inserted in 5% of men, a urethral stricture was observed in 1.2%. Only hospital stay was independently predictive of persistent urinary incontinence on multivariate analysis p¼0.018 OR 1.78 (95% CI 1.106-2.876).
CONCLUSIONS: Men who stay longer in hospital are more likely to experience incontinence. Hospital stay is a likely surrogate for early complications, more extensive surgery or bleeding. A better classification of postoperative complications after radical prostatectomy for high risk prostate cancer may allow prediction of postoperative continence.
Source of Funding: None

MP93-08 INTERPRETING PATIENT-REPORTED URINARY AND SEXUAL FUNCTION OUTCOMES ACROSS MULTIPLE VALIDATED INSTRUMENTS
Emily Vertosick, Andrew Vickers*, New York, NY; Janet Cowan, Jeanette Broering, Peter Carroll, Matthew Cooperberg, San Francisco, CA INTRODUCTION AND OBJECTIVES: For purposes of both research and clinical quality assurance, doctors must be able to report and compare their results. In prostate cancer, comparing critical patient-reported outcomes such as urinary and erectile function is complicated by the use of different questionnaires, with some centers using EPIC, others using PCI and others using separate instruments for urinary and erectile score (e.g. SHIM and IPSS). We aimed to develop a method to convert scores between these four commonly used instruments.
METHODS: Patient-reported data on urinary and sexual function were collected from 1,284 men with localized prostate cancer using Vol. 197, No. 4S, Supplement, Tuesday, May 16, 2017 THE JOURNAL OF UROLOGY â e1239 the Expanded Prostate Index Composite (EPIC-26), UCLA Prostate Cancer Index (PCI), Sexual Health Inventory for Men (SHIM) and International Prostate Symptom Scale (IPSS) questionnaires. We investigated several methods to convert scores between questionnaires. RESULTS: Conversion between EPIC and PCI urinary and sexual function subscales is best achieved using only the subset of questions that were asked on both questionnaires. This means that sexual function focuses on erectile function and does not include libido, which is include only on the PCI. For the conversion between EPIC or PCI erectile function scores and the SHIM scores, we defined equivalent thresholds of poor, intermediate or good function respectively: EPIC/PCI 0 -40 and SHIM 1-7; EPIC/PCI 41 -59 and SHIM 8-16; EPIC/ PCI 60 -100 and SHIM 17-25. Urinary continence scores are highly correlated between PCI and EPIC (r¼0.94). Multiple attempts were made to compare IPSS with EPIC and PCI, but after investigation, no comparison was possible due to differences in domains addressed by these questionnaires. Therefore, we do not believe a conversion between IPSS and either PCI or EPIC is appropriate.
CONCLUSIONS: We have introduced methods for converting scores between the EPIC, PCI and SHIM questionnaires. While these conversion methods may introduce a minor amount of imprecision, such imprecision is dwarfed by other factors (such as case mix and statistical imprecision). Our methods represent the best available tools for combining and comparing patient-reported outcomes assessed using different instruments. 
Source of
MP93-09
PREDICTORS OF MEMBRANOUS URETHRAL LENGTH MEASUREMENT PRIOR TO RADICAL PROSTATECTOMY
Sean Mungovan*, Westmead , Australia; Petra Graham, Sydney, Australia; Jaspreet Sandhu, Oguz Akin, New York, NY; Manish Patel, Westmead , Australia INTRODUCTION AND OBJECTIVES: Patient anatomical factors including the preoperative measurement of the membranous urethral length (MUL) have been reported to affect the time to achieve continence following radical prostatectomy (RP). There is limited data available reporting the relationship between patient anthropometric measures and also the test-retest reliability of MUL measurements from separate MRI investigations. Objectives: We sought to investigate i) if patient related anthropometric factors were associated with MUL measurements in men prior to RP and ii) the test-retest reliability of preoperative MUL measurements from separate MRI investigations.
METHODS: 119 preoperative T2 weighted sagittal prostate MRI's were cross-referenced with coronal images for the measurement of MUL. Preoperative MUL was measured three times and the mean of the three measures was recorded for analysis. A linear model was used for the regression of MUL against predictive variables height, body mass, BMI and age. Nine patients who had undergone two separate preoperative prostate MRI investigations were identified to assess the test-retest reliability of MUL measurements. An intra class correlation coefficient (ICC) using a two-way mixed-model was used to assess the reliability of the test-retest preoperative MUL measurements.
RESULTS: The 119 patients had a mean age of age 65 8yrs, mean height 1.72 0.07m, mean body mass 84 12.8kg and a mean BMI 27.8 4.6 kg.m2. MUL was not associated with height (p¼0.713), body mass (p¼0.894), BMI (p¼0.985) or age (p¼0.189). For the 9 patients with two separate prostate MRI investigations, there was excellent testretest reliability for the preoperative measurement of MUL ICC¼0.989 (95%CI: 0.935, 0.998). The average time between MRI investigations was 35 64 days.
CONCLUSIONS: Patient anthropometric measurements are not related to MUL in men prior to RP. The two repeated measurements of MUL from separate MRI investigations indicates that MUL is a stable measurement, but due to the small sample size further investigation is warranted. INTRODUCTION AND OBJECTIVES: Given the various treatment options available to men diagnosed with prostate cancer, optimal urinary, sexual, and bowel function should be goals of care in addition to disease free survival. This study assesses factors including management decision for localized prostate cancer and their association with urinary, bowel, and sexual function at 2 years following definitive procedural treatment (radical prostatectomy (RP) or brachytherapy (BT)) or active surveillance (AS).
Source of Funding: None
METHODS: An institutional review of 572 patients who underwent definitive procedural treatment or AS and completed a validated Prostate Health Related Quality of Life Questionnaire at both the time of treatment selection and at 2 year follow-up. Urinary, sexual, and bowel function at 2 years were assessed by self-reported responses to 3 separate questions asking, "Overall, how big a problem has your urinary/sexual/bowel function been for you during the last 4 weeks?" Patient and disease characteristics, baseline urinary, sexual and bowel function, and management selection were analyzed on multivariable logistic regression models for 2 year function outcomes.
RESULTS: The median age in this cohort was 62 years (IQR: 57-68) with 109 (19%) patients who elected BT, 102 (18%) participated in AS, and 361 (63%) received RP. On multivariable logistic regression for urine function at 2 years, BT vs. AS (HR: 5.4, p ¼ 0.011) and RP vs. AS (HR: 4.0, p ¼ 0.026) associated with worse urinary function. Presence of a partner was associated with better preservation of sexual function (HR: 0.4, p ¼ 0.009), while RP vs. AS (HR: 2.2, p ¼ 0.013) was associated with worse sexual function at 2 years. Significant baseline bowel bother associated with worse bowel function at 2 years (HR: 11.7, p <0.0001); however, type of management was not significantly associated with adverse bowel function.
CONCLUSIONS: The 2 year urinary, sexual and bowel functions among patients managed for localized prostate cancer are based on multiple patient characteristics in addition to the shared decision for BT, RP or AS. Additional studies should examine matched function outcomes among men managed for localized prostate cancer. 197, No. 4S, Supplement, Tuesday, May 16, 2017 
